Researchers from Yale-NUS College have made a significant discovery that could change how we understand Alzheimer’s disease, ...

Westend61/Getty Images A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide ...

In a major discovery, scientists have presented the first evidence of Alzheimer's disease transmission in living individuals.

For decades, scientists have focused on beta-amyloid plaques as the primary cause of Alzheimer's disease. These protein ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...

Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...

Two new treatments, including Carr’s, target toxic clumps of a protein called amyloid beta in the brain and are the first to slow progression of the illness. Blood tests could revolutionize the ...

Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.

The deal between the two companies aims to develop an artificial intelligence driven platform designed to cut out PET scans.

In Alzheimer’s disease, some astrocytes serve as celestial guardians that break down the amyloid beta protein plaques that build up in the brain; others, however, go rogue, actually secreting ...

A year later, they published a paper that pointed to the buildup of the protein beta-amyloid as a prime driver of early onset Alzheimer’s. “Once we showed that amyloid could drive this ...